Clinical guidance for smallpox vaccine use in a postevent vaccination program [0.03%]
天花疫苗事件后接种指导意见临床指引
Brett W Petersen,Inger K Damon,Carol A Pertowski et al.
Brett W Petersen et al.
This report outlines recommendations for the clinical use of the three smallpox vaccines stored in the U.S. Strategic National Stockpile for persons who are exposed to smallpox virus or at high risk for smallpox infection during a postevent...
James B Holt,Sara L Huston,Khosrow Heidari et al.
James B Holt et al.
Chronic diseases are an important public health problem, which can result in morbidity, mortality, disability, and decreased quality of life. Chronic diseases represented seven of the top 10 causes of death in the United States in 2010 (Mur...
Rachel Holloway,Sonja A Rasmussen,Stephanie Zaza et al.
Rachel Holloway et al.
The complexities of planning for and responding to the emergence of novel influenza viruses emphasize the need for systematic frameworks to describe the progression of the event; weigh the risk of emergence and potential public health impac...
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP) [0.03%]
人乳头瘤病毒疫苗接种咨询委员会(ACIP)推荐意见
Lauri E Markowitz,Eileen F Dunne,Mona Saraiya et al.
Lauri E Markowitz et al.
This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations fr...
Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs [0.03%]
关于美国疾病预防控制中心和美国人口事务办公室的计划生育服务建议
Loretta Gavin,Susan Moskosky,Marion Carter et al.
Loretta Gavin et al.
This report provides recommendations developed collaboratively by CDC and the Office of Population Affairs (OPA) of the U.S. Department of Health and Human Services (HHS). The recommendations outline how to provide quality family planning s...
Revised surveillance case definition for HIV infection--United States, 2014 [0.03%]
2014年美国HIV感染监测病例定义修订版
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC)
Following extensive consultation and peer review, CDC and the Council of State and Territorial Epidemiologists have revised and combined the surveillance case definitions for human immunodeficiency virus (HIV) infection into a single case d...
Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014 [0.03%]
2014年沙眼衣原体和淋病奈瑟菌实验室检测建议
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
This report updates CDC's 2002 recommendations regarding screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections (CDC. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. M...
Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP) [0.03%]
b型流感嗜血杆菌病的预防和控制：免疫实践咨询委员会（acip）的建议
Elizabeth C Briere,Lorry Rubin,Pedro L Moro et al.
Elizabeth C Briere et al.
This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of Haemophilus influenzae type b (Hib) disease in the United States. As a comprehensive ...
CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management [0.03%]
美国疾控中心关于评价医务人员乙型肝炎病毒保护和从事岗后管理的指导意见
Sarah Schillie,Trudy V Murphy,Mark Sawyer et al.
Sarah Schillie et al.
This report contains CDC guidance that augments the 2011 recommendations of the Advisory Committee on Immunization Practices (ACIP) for evaluating hepatitis B protection among health-care personnel (HCP) and administering post-exposure prop...
Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis [0.03%]
关于贝达喹啉焦磷酸盐（斯布鲁）用于治疗耐多药结核病的使用和安全监测暂行指南（CDC发布）
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Multidrug-resistant tuberculosis (MDR TB) is caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampin, the two most effective of the four first-line TB drugs (the other two drugs being ethambutol and pyrazin...